BioSpace News Archive

Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global particle-enhanced turbidimetric immunoassays market is projected to exhibit strong growth during the forecast period, from 2021 and 2031.

Rising consumer spending has facilitated steady growth within the overall personal care industry in the recent past.

The global market for ENT disorder is expected to be on course to achieve stellar valuation in the coming few years of the forecast period.

The penetration of healthcare IT in patient care has underpinned the steady evolution of patient engagement with the health systems world over.

High acknowledgment of cutting edge innovations, developing interest for unifying, and smoothing out of healthcare data, rising mindfulness among patients for clinical data stockpiling and the executives, and expanding government drives will uphold the development of the worldwide personal health record software market.

Biotage AB has entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited based in Oxford and Southampton, UK, for a total purchase price of approx.

Crescendo Biologics Ltd, a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, announces a new translational science collaboration with The Institute of Cancer Research, London, one of the world’s most influential cancer research organisations.

It’s exciting and quite an honor to have an opportunity to be interviewed by Kathy Ireland on Worldwide Business and to share the corporate vision that we have at Sino Biological.

NeuroMetrix, Inc. announced that it has appointed Susan M. Bell as Senior Vice President, Population Health & Value Based Care.

ImCheck Therapeutics announced today the publication of the preclinical to clinical development of its lead immuno-oncology program, ICT01.